(Q46858826)

English

MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis

scientific article published on 21 July 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

steatohepatitis

0 references

non-alcoholic steatohepatitis

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

author name string

Josef Wanninger

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

Roland Walter

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

Sabrina Bauer

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

Kristina Eisinger

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

Andreas Schäffler

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

Christoph Dorn

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

Claus Hellerbrand

8

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

Christa Buechler

9

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

publication date

21 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

91

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

603-607

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

Effects of adiponectin on human trophoblast invasion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Adiponectin is a potential catabolic mediator in osteoarthritis cartilage

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Differential expression of matrix metalloproteinases in viral and non-viral chronic liver diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Animal models of non-alcoholic steatohepatitis: of mice and man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Decreased plasma adiponectin concentrations are closely associated with nonalcoholic hepatic steatosis in obese individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Charitable State-Controlled Foundation Human Tissue and Cell Research: Ethic and Legal Aspects in the Supply of Surgically Removed Human Tissue For Research in the Academic and Commercial Sector in Germany

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

The role of cytokines in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Adiponectin increases MMP-3 expression in human chondrocytes through AdipoR1 signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.07.001

7 January 2021

Identifiers

10.1016/J.YEXMP.2011.07.001

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21791204

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46858826&oldid=2135143693"